GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.

Tencent was among the investors in a $10m series A round for the digital health platform that was co-led by Global Ventures and Africa Healthcare Masterfund.

Novo Holdings has joined the early-stage consortium of Praxis Precision, a gene therapy business targeting neurological mechanisms across CNS-driven and psychiatric diseases.

At-home clinical testing services provider LetsGetChecked has raised $71m from investors including Illumina and Optum as it faces increased demand.

Posco-backed medical device developer Pulmonx has added $66m to its coffers thanks to a consortium led by Ally Bridge and secured an additional $17m to refinance a debt facility.

Novo Holdings has joined the early-stage consortium of Praxis Precision, a gene therapy business co-founded by faculty from Columbia and Melbourne universities.

PPD has backed clinical trial preparation software developer Medable as an existing investor having also partnered the business to launch a telemedicine-based clinical trial product last year.

The food and nutrition business picked up backers including Fosun International and existing investor Qualcomm Ventures after earlier rounds in 2011 and 2014.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

COO Jon Eide and partner Dusty Lieb have spoken to GCV about the balance between pursuing more attractive valuations while dealing with differing expectations from its healthtech portfolio.